Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts; studies of normal polyclonal T cells and T lymphocyte clones derived early after allogeneic bone marrow transplantation Ø. BruserudGraham Pawelec ORIGINAL ARTICLE Pages: 133 - 140
Human neutrophil interactions of a bispecific monoclonal antibody targeting tumor and human Fcγ RIII L. M. WeinerR. Katherine AlpaughMalcolm W. Barth ORIGINAL ARTICLE Pages: 141 - 150
HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions Carys EvansStefan BauerG. B. Lipford ORIGINAL ARTICLE Pages: 151 - 160
Therapeutic effectiveness of the immunity elicited by P815 tumor cells engineered to express the B7-2 costimulatory molecule Ross N. La MotteMichael A. RubinM. B. Mokyr ORIGINAL ARTICLE Pages: 161 - 169
Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility- complex-negative human tumour: neuroblastoma Paola FacchettiI. PrigioneVito Pistoia ORIGINAL ARTICLE Pages: 170 - 178
Humoral and cellular responses raised against the human HER2 oncoprotein are cross-reactive with the homologous product of the neu proto-oncogene, but do not protect rats against B104 tumors expressing mutated neu Peter TaylorMarlene GerderMarc Feldmann ORIGINAL ARTICLE Pages: 179 - 184
Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line L. BjørgeTone Skeie JensenRoald Matre ORIGINAL ARTICLE Pages: 185 - 192
Cellular immune responses to autologous chronic myelogenous leukaemia cells in vitro Graham PawelecArnika RehbeinPaul da Silva ORIGINAL ARTICLE Pages: 193 - 199
Autoantibodies against p53 are not increased in human ascites and pleural effusions Reinhold MunkerOliver StötzerWolfgang Wilmanns SHORT COMMUNICATION Pages: 200 - 201